Renal Cell Carcinoma Recurrent

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-14
Clinical Trial Update: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy [Phase 3]
Phase 3 trial evaluating the impact of PRO coaching on patient-reported outcomes in frontline advanced or metastatic renal cell carcinoma, c…